Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.
暂无分享,去创建一个
Tobias Blaschke | Monika Schäfer-Korting | Johanna Plendl | Sarah Küchler | Michał R. Radowski | R. Haag | M. Dathe | M. Schäfer-Korting | Rainer Haag | J. Plendl | Michal R Radowski | Margitta Dathe | Klaus D Kramer | S. Küchler | K. Kramer | T. Blaschke
[1] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[2] M Simeonova,et al. Nanoparticles as drug carrier system of 5-fluorouracil in local treatment of patients with superficial basal cell carcinoma. , 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[3] R. Bittl,et al. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[4] R. Mülhaupt,et al. Controlled Synthesis of Hyperbranched Polyglycerols by Ring-Opening Multibranching Polymerization , 1999 .
[5] P. Weigel,et al. Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. , 1985, The Journal of biological chemistry.
[6] Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy. , 2007, Advanced drug delivery reviews.
[7] F. Bonte,et al. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. , 1993, Journal of pharmaceutical sciences.
[8] B. Röder,et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[9] R H Guy,et al. Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[10] H. Höltje,et al. Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action , 2005, Skin Pharmacology and Physiology.
[11] H. Maibach,et al. Liposomes and Niosomes as Topical Drug Delivery Systems , 2005, Skin Pharmacology and Physiology.
[12] H. Korting,et al. Lipid nanoparticles for improved topical application of drugs for skin diseases. , 2007, Advanced drug delivery reviews.
[13] M. Schoenfisch,et al. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. , 2007, Biomacromolecules.
[14] C. Zouboulis,et al. Cyproterone Acetate Loading to Lipid Nanoparticles for Topical Acne Treatment: Particle Characterisation and Skin Uptake , 2007, Pharmaceutical Research.
[15] M. Schaller,et al. Drug Targeting by Solid Lipid Nanoparticles for Dermal Use , 2002, Journal of drug targeting.
[16] Claus-Michael Lehr,et al. The Use of Reconstructed Human Epidermis for Skin Absorption Testing: Results of the Validation Study , 2008, Alternatives to laboratory animals : ATLA.
[17] K. Landfester,et al. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. , 2006, Biomaterials.
[18] Nissim Garti,et al. Microemulsions as transdermal drug delivery vehicles. , 2006, Advances in colloid and interface science.
[19] Michał R. Radowski,et al. Supramolecular aggregates of dendritic multishell architectures as universal nanocarriers. , 2007, Angewandte Chemie.
[20] J. Lademann,et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.
[21] Michael S Roberts,et al. Molecular size as the main determinant of solute maximum flux across the skin. , 2004, The Journal of investigative dermatology.
[22] S. Fowler,et al. Spectrofluorometric studies of the lipid probe, nile red. , 1985, Journal of lipid research.
[23] E. Waigmann,et al. Detection of nanometer-sized particles in living cells using modern fluorescence fluctuation methods. , 2005, Biochemical and biophysical research communications.
[24] P. Couvreur,et al. Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models , 2007, Journal of drug targeting.
[25] M. Fantini,et al. Reverse Hexagonal Phase Nanodispersion of Monoolein and Oleic Acid for Topical Delivery of Peptides: in Vitro and in Vivo Skin Penetration of Cyclosporin A , 2006, Pharmaceutical Research.
[26] J. Ring,et al. Improved risk–benefit ratio for topical triamcinolone acetonide in Transfersome® in comparison with equipotent cream and ointment: a randomized controlled trial , 2003, The British journal of dermatology.
[27] S. Wartewig,et al. Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy , 2005, Pharmaceutical Research.
[28] M. Schäfer-Korting,et al. Liposomal tretinoin for uncomplicated acne vulgaris , 1994, The clinical investigator.
[29] J. M. Marchetti,et al. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study , 2001, BMC dermatology.
[30] Geoffrey Lee. Prediction of Percutaneous Penetration , 1997 .
[31] R. Haag,et al. Supramolecular drug-delivery systems based on polymeric core-shell architectures. , 2004, Angewandte Chemie.
[32] J A Bouwstra,et al. Skin structure and mode of action of vesicles. , 2002, Advanced drug delivery reviews.
[33] Hatem Fessi,et al. Enhancement of Topical Delivery from Biodegradable Nanoparticles , 2004, Pharmaceutical Research.
[34] S. Nacht,et al. The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. , 1996, Journal of microencapsulation.
[35] Michael A Repka,et al. Characterization of hot-melt extruded drug delivery systems for onychomycosis. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[36] M. Schaller,et al. Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and X-ray microanalysis , 1997, Antimicrobial agents and chemotherapy.
[37] M Schaller,et al. Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles , 1996, The British journal of dermatology.
[38] H. Hamm,et al. Dendritic molecular transporters provide control of delivery to intracellular compartments. , 2007, Bioconjugate chemistry.
[39] Claus-Michael Lehr,et al. Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study , 2006, Alternatives to laboratory animals : ATLA.
[40] Kumar A. Shah,et al. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. , 2007, International journal of pharmaceutics.
[41] S. Wissing,et al. The influence of the crystallinity of lipid nanoparticles on their occlusive properties. , 2002, International journal of pharmaceutics.
[42] G. Cevc. Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.
[43] C. Bocca,et al. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. , 2000, International journal of pharmaceutics.
[44] G. Ogden,et al. A technique for the study of endocytosis in human oral epithelial cells. , 1999, Archives of oral biology.
[45] H. Korting,et al. Prednicarbate Biotransformation in Human Foreskin Keratinocytes and Fibroblasts , 1997, Pharmaceutical Research.
[46] H. Korting,et al. Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[47] H. Maibach,et al. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. , 1991, Journal of the American Academy of Dermatology.